- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06048822
Enhancing Cancer Survivorship With Pickleball
March 5, 2026 updated by: H. Lee Moffitt Cancer Center and Research Institute
Project Rally: Enhancing Cancer Survivorship With Pickleball
The purpose of the study is to evaluate the feasibility and acceptability of a pickleball program for cancer survivors and their family members or friends.
The program is designed to increase physical activity, improve wellness, and allow individuals to work together to learn and practice the sport.
Study Overview
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age > 18 years
- History of a cancer diagnosis excluding squamous and basal cell skin cancers
- Able to speak and read English
- Able to provide informed consent
- Able to pass a 2023 Physical Activity Readiness Questionnaire+ (PAR-Q+) (with appropriate physician clearance(s), as necessary)
- History of cancer diagnosis will be required for cancer survivor group; friend or family partners can be (but do not need to be) cancer survivors.
Exclusion Criteria:
- Screen failure for exercise safety based on 2023 PAR-Q+
- For cancer survivor group, history of squamous and basal cell skin cancers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cancer Survivors
Participation will last approximately 4-6 months.
Participants will be encouraged to attend Pickleball sessions at the YMCA at least twice a week.
Each session will last 2 hours, and participants will be encouraged to attend at least one hour.
Participants will receive a Fitbit to wear continuously 24/7 over 4-6 months to track steps and activity intensity.
Participants will also be asked to wear an electronic device (accelerometer) over their right hip during specific time points throughout the study to better understand how pickleball participation contributes to physical activity levels.
|
Participants will be encouraged to attend ≥2 pickleball sessions per week, with the YMCA offering 5 sessions per week.
Sessions will last 2 hours, with participants encouraged to attend ≥1 hour.
New players will receive instruction from a YMCA exercise trainer with a USA Pickleball Association Instructor Certification during sessions.
At the end of each session, the YMCA trainer will note on attendance sheets whether participants engaged in training/skill development, open play, or both.
Participants will be encouraged to engage in 5-10 minutes of structured warm-up exercise (i.e., walking laps around the courts and dynamic and static muscle stretches) prior to playing in each session, and they will be encouraged to perform cool-down stretches after they complete each session.
|
|
Experimental: Family or Friend of Cancer Survivors
Participation will last approximately 4-6 months.
Participants will be encouraged to attend Pickleball sessions at the YMCA at least twice a week.
Each session will last 2 hours, and participants will be encouraged to attend at least one hour.
Participants will receive a Fitbit to wear continuously 24/7 over 4-6 months to track steps and activity intensity.
Participants will also be asked to wear an electronic device (accelerometer) over their right hip during specific time points throughout the study to better understand how pickleball participation contributes to physical activity levels.
|
Participants will be encouraged to attend ≥2 pickleball sessions per week, with the YMCA offering 5 sessions per week.
Sessions will last 2 hours, with participants encouraged to attend ≥1 hour.
New players will receive instruction from a YMCA exercise trainer with a USA Pickleball Association Instructor Certification during sessions.
At the end of each session, the YMCA trainer will note on attendance sheets whether participants engaged in training/skill development, open play, or both.
Participants will be encouraged to engage in 5-10 minutes of structured warm-up exercise (i.e., walking laps around the courts and dynamic and static muscle stretches) prior to playing in each session, and they will be encouraged to perform cool-down stretches after they complete each session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Recruited - Feasibility
Time Frame: 12 months
|
The study will be deemed feasible if ≥ 50% of eligible participants are enrolled
|
12 months
|
|
Number of Participants who Complete Baseline Data Collection and Follow up Data Collection - Feasibility
Time Frame: 6 months
|
The study will be deemed feasible if ≥ 75% of participants who complete baseline measures also complete follow up measures
|
6 months
|
|
Average Pickleball Session Attendance - Feasibility
Time Frame: 6 months
|
The study will be deemed feasible if participants attend ≥ 75% of recommended sessions on average.
|
6 months
|
|
Participant Evaluation of Feasibility and Acceptability - Acceptability
Time Frame: 6 months
|
Participants evaluation of feasibility and acceptability will be assessed with a questionnaire, adapted to fit the intervention.
The questionnaire includes both Likert Scale and open-ended questions.
An item-by-item basis and as average item score, with scores ≥4 ("agree" to "strongly agree") indicating acceptability.
Open-ended responses will be analyzed qualitatively to inform intervention improvement.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nathan Parker, PhD, MPH, Moffitt Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2023
Primary Completion (Actual)
May 10, 2024
Study Completion (Actual)
May 10, 2024
Study Registration Dates
First Submitted
September 15, 2023
First Submitted That Met QC Criteria
September 15, 2023
First Posted (Actual)
September 21, 2023
Study Record Updates
Last Update Posted (Actual)
March 6, 2026
Last Update Submitted That Met QC Criteria
March 5, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCC-22455
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on Pickleball
-
Midwestern UniversityCreighton UniversityCompletedParkinson DiseaseUnited States
-
Penn State UniversityRecruitingAutism Spectrum DisorderUnited States
-
Elif TopBurdur Mehmet Akif Ersoy UniversityActive, not recruitingIntellectual Disability, MildTurkey (Türkiye)